74
Participants
Start Date
August 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Oxytocin
Gel for intravaginal use, 600 IU once per day for 2 weeks followed by 600 IU twice a week for ten weeks
Placebo
Gel for intravaginal use of identical appearance as active substance, once per day for two weeks followed by twice a week for ten weeks
Karolinska University Hospital-Huddinge, Huddinge
Uppsala University Hospital, Uppsala
Northwick Park & St Marks Hospital NHS Trust, Harrow Middlesex
Lead Sponsor
PepTonic Medical AB
INDUSTRY